Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dawson M. Knoblock"'
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Supplemental Table 2: Number of patients in each cohort with any seroreactivity against the candidate antigens (HPV 16,18 E6 and E7) at (A) any timepoint following vaccination and (B) three months following final vaccination Supplemental Table 3: Flo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00eabed1abfd4b80f484b655c53dec8d
https://doi.org/10.1158/1078-0432.22472916.v1
https://doi.org/10.1158/1078-0432.22472916.v1
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Purpose:Clinical responses with programmed death (PD-1) receptor–directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa). Viral neoantigens, such as the E6/E7 proteins of HPV16/18, are attractive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6796bfeadb07acc04de8d95a04654454
https://doi.org/10.1158/1078-0432.c.6528372
https://doi.org/10.1158/1078-0432.c.6528372
Autor:
Mark L. Bagarazzi, Ildiko Csiki, David Weiner, Rakesh Kumar, Mark Esser, Susan Duff, Sandra Oyola, Michael Dallas, Russell Vang, Drishty Mangrolia, Kelsie Dickerson, Aubrey Anton, Sophie Tan, Lindsay Sakata, Jean Boyer, Alexander Lin, Gregory S. Weinstein, Joshua M. Bauml, Dawson M. Knoblock, Albert J. Sylvester, Kimberly A. Kraynyak, Matthew P. Morrow, Roger B. Cohen, Charu Aggarwal
Supplemental legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51803170b0d9f9397e5106bcc930d031
https://doi.org/10.1158/1078-0432.22472922.v1
https://doi.org/10.1158/1078-0432.22472922.v1
Autor:
Rafael Winograd, Jae W. Lee, Whitney L. Gladney, Cynthia Clendenin, Santiago L. Luque, Kristen B. Long, Gregory L. Beatty, Robert H. Vonderheide, Rebecca A. Evans, Patrick Guirnalda, Dawson M. Knoblock
Publikováno v:
Gastroenterology. 149:201-210
Background & Aims Immunotherapies that induce T-cell responses have shown efficacy against some solid malignancies in patients and mice, but these have little effect on pancreatic ductal adenocarcinoma (PDAC). We investigated whether the ability of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c0dcd1c3ff2dc7f9dcf664b9ed20ed
https://doi.org/10.1053/j.gastro.2015.04.010
https://doi.org/10.1053/j.gastro.2015.04.010
The ability of some tumors to exclude effector T cells represents a major challenge to immunotherapy. T cell exclusion is particularly evident in pancreatic ductal adenocarcinoma (PDAC), a disease where blockade of the immune checkpoint molecule CTLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d991b2c1a2c486a20aaf09f46636d573
https://europepmc.org/articles/PMC5677559/
https://europepmc.org/articles/PMC5677559/
Autor:
Terry C. Fang, Yumi Yashiro-Ohtani, Dawson M. Knoblock, Cristina Del Bianco, Stephen C. Blacklow, Warren S. Pear
Publikováno v:
Immunity. 27:100-110
SummaryNotch signaling plays multiple roles to direct diverse decisions regarding cell fate during T cell development. During helper T (Th) cell differentiation, Notch is involved in generating optimal Th2 cell responses. Here, we present data invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb38dc6a0b2a017aba2aeef8921c3aff
https://doi.org/10.1016/j.immuni.2007.04.018
https://doi.org/10.1016/j.immuni.2007.04.018